Uk medicines authority registers AstraZeneca’s COVID-19 antibody Evusheld

AstraZeneca’s Evusheld has been approved for use by the Medicines and Healthcare products Regulatory Agency (MHRA). It is the first antibody preparation approved in the UK to prevent coronavirus infection. The drug is recommended for those who are at risk for COVID-19 due to their underlying disease or other non-vaccination reasons.